Please use this identifier to cite or link to this item: http://hdl.handle.net/1893/24366
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOverbye, Marieen_UK
dc.contributor.authorWagner, Ulriken_UK
dc.date.accessioned2016-10-05T21:58:41Z-
dc.date.available2016-10-05T21:58:41Z-
dc.date.issued2013-11en_UK
dc.identifier.urihttp://hdl.handle.net/1893/24366-
dc.description.abstractBackground: have a medical condition. If so, a Therapeutic Use Exemption (TUE) is required. The boundaries between the use of pharmacological substances due to a medical need and doping are sometimes blurred. Although manipulating the system of TUE granting potentially represents an entry stage for doping, few studies examine how athletes perceive TUE management and relate this to current anti-doping policy.Athletes can be allowed to use substances from the prohibited list (the doping list) if they  Methods: questionnaire about their experience and perception of TUE (response rate: 43%).645 Danish elite athletes (mean age 22.12, SD = 5.82) representing 40 sports completed a webbased  Results: of the TUE system as necessary to compete on equal terms with other athletes. Administrative hurdles for TUE prevented 7% of athletes from applying. 53% of the athletes considered that being “allowed” to dope by means of a TUE was of importance for their (hypothetical) wish to try out doping. 51% believed that athletes in their sport received TUEs without a medical need. Athletes granted TUEs had more than twice as high odds to distrust the efficacy of the system than athletes never granted a TUE. The belief that TUEs were misused was especially common among endurance athletes, regardless of them having experience with TUEs or not. 4% believed it would be okay to receive a TUE without a medical need.19% of the respondents had been granted a TUE. 85% of athletes granted a TUE regarded their use  Conclusion: administration increases once an athlete has experience of TUEs represents a challenge for anti-doping policy. We suggest more critical research on TUEs be carried out in order to improve harmonization and increase transparency in the regulations.The results confirm that TUE is a problem in anti-doping policy. The fact that distrust in TUEen_UK
dc.language.isoenen_UK
dc.publisherElsevieren_UK
dc.relationOverbye M & Wagner U (2013) Between medical treatment and performance enhancement: An investigation of how elite athletes experience Therapeutic Use Exemptions. International Journal of Drug Policy, 24 (6), pp. 579-588. https://doi.org/10.1016/j.drugpo.2013.03.007en_UK
dc.rightsThe publisher does not allow this work to be made publicly available in this Repository. Please use the Request a Copy feature at the foot of the Repository record to request a copy directly from the author. You can only request a copy if you wish to use this work for your own research or private study.en_UK
dc.rights.urihttp://www.rioxx.net/licenses/under-embargo-all-rights-reserveden_UK
dc.subjectWorld Anti-Doping Codeen_UK
dc.subjectSports medicineen_UK
dc.subjectDopingen_UK
dc.subjectWADAen_UK
dc.subjectAthletes’ attitudesen_UK
dc.subjectSurveyen_UK
dc.titleBetween medical treatment and performance enhancement: An investigation of how elite athletes experience Therapeutic Use Exemptionsen_UK
dc.typeJournal Articleen_UK
dc.rights.embargodate2999-12-10en_UK
dc.rights.embargoreason[Overbye-Wagner-IJDP-2013.pdf] The publisher does not allow this work to be made publicly available in this Repository therefore there is an embargo on the full text of the work.en_UK
dc.identifier.doi10.1016/j.drugpo.2013.03.007en_UK
dc.identifier.pmid23582632en_UK
dc.citation.jtitleInternational Journal of Drug Policyen_UK
dc.citation.issn0955-3959en_UK
dc.citation.volume24en_UK
dc.citation.issue6en_UK
dc.citation.spage579en_UK
dc.citation.epage588en_UK
dc.citation.publicationstatusPublisheden_UK
dc.citation.peerreviewedRefereeden_UK
dc.type.statusVoR - Version of Recorden_UK
dc.author.emailmarie.overbye@stir.ac.uken_UK
dc.citation.date09/04/2013en_UK
dc.contributor.affiliationSporten_UK
dc.contributor.affiliationUniversity of Southern Denmarken_UK
dc.identifier.isiWOS:000330918700011en_UK
dc.identifier.scopusid2-s2.0-84890434305en_UK
dc.identifier.wtid550581en_UK
dc.contributor.orcid0000-0003-4066-6360en_UK
dc.date.accepted2013-03-11en_UK
dcterms.dateAccepted2013-03-11en_UK
dc.date.filedepositdate2016-10-05en_UK
rioxxterms.typeJournal Article/Reviewen_UK
rioxxterms.versionVoRen_UK
local.rioxx.authorOverbye, Marie|0000-0003-4066-6360en_UK
local.rioxx.authorWagner, Ulrik|en_UK
local.rioxx.projectInternal Project|University of Stirling|https://isni.org/isni/0000000122484331en_UK
local.rioxx.freetoreaddate2999-12-10en_UK
local.rioxx.licencehttp://www.rioxx.net/licenses/under-embargo-all-rights-reserved||en_UK
local.rioxx.filenameOverbye-Wagner-IJDP-2013.pdfen_UK
local.rioxx.filecount1en_UK
local.rioxx.source0955-3959en_UK
Appears in Collections:Faculty of Health Sciences and Sport Journal Articles

Files in This Item:
File Description SizeFormat 
Between medical treatment and performance enhancement_An investigation of how elite athletes experience Therapeutic Use Exemptions.pdf1 MBAdobe PDFUnder Permanent Embargo    Request a copy
Overbye-Wagner-IJDP-2013.pdfFulltext - Published Version1 MBAdobe PDFUnder Embargo until 2999-12-10    Request a copy


This item is protected by original copyright



Items in the Repository are protected by copyright, with all rights reserved, unless otherwise indicated.

The metadata of the records in the Repository are available under the CC0 public domain dedication: No Rights Reserved https://creativecommons.org/publicdomain/zero/1.0/

If you believe that any material held in STORRE infringes copyright, please contact library@stir.ac.uk providing details and we will remove the Work from public display in STORRE and investigate your claim.